Roche Gains CE Mark Approval for Elecsys pTau217 Test
BASEL, Switzerland, May 12, 2026 Roche announced that it has received European CE Mark approval for Elecsys® plasma phosphorylated-tau...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BASEL, Switzerland, May 12, 2026 Roche announced that it has received European CE Mark approval for Elecsys® plasma phosphorylated-tau...
ABBOTT PARK, Illinois, USA, April 28, 2026 Abbott has announced that its next-generation Ultreon™ 3.0 AI-powered coronary imaging platform...
BURLINGTON, Massachusetts, USA, April 28, 2026 SQ Innovation has announced that its drug-device combination therapy Lasix® ONYU has achieved...
BASEL, Switzerland, April 13, 2026 Roche has announced that its Elecsys® Neurofilament Light Chain (NfL) blood test has received...
IRVINE, California, United States, April 7, 2026 Johnson & Johnson MedTech announced the European launch of VARIPULSE™ Pro, an...
Middle East Partnership Advances Neurostimulation Care – February 18, 2026 | Mont-Saint-Guibert, Belgium Nyxoah has signed a Memorandum of...
SEOUL, South Korea, Jan. 30, 2026 — Cynosure Lutronic announced the successful completion of European Union Medical Device Regulation...
Madrid | January 28, 2026 — Corify Care, a cardiovascular MedTech innovator, announced a major advancement in cardiac electrophysiology...
Solana Beach, California | January 22, 2026 ClearPoint Neuro has announced the successful EU Medical Device Regulation (EU MDR)...
Abbott Park, Illinois, December 18, 2025 — Abbott has secured U.S. Food and Drug Administration (FDA) clearance and CE...
